<DOC>
	<DOCNO>NCT00350103</DOCNO>
	<brief_summary>The purpose trial ass whether 400mg/day lacosamide effective reduce pain cause distal diabetic neuropathy . Two dose-escalation scheme lacosamide use determine efficacy `` standard '' scheme evaluate efficacy safety rapid titration scheme . Subjects randomly assign one three treatment group . Subjects two group receive lacosamide dose 400mg/day , different dose-escalation scheme use reach final dose . The third group subject receive placebo . Subjects 2 3 ( 66 % ) chance get lacosamide . The maximum lacosamide dose trial 400mg/day . The maximum treatment duration 18 week , include two-week Pre-Treatment Phase 12 week period stable dose lacosamide placebo .</brief_summary>
	<brief_title>A Trial Assess Efficacy Safety 400mg/Day Lacosamide Subjects With Painful Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject symptom painful diabetic neuropathy least 6 month diagnosis diabetes mellitus ( Type I Type II ) . Subject previously participate trial subject previously assign treatment trial drug investigation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>